Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The White House and CDC will offer vaccines to more people at risk, particularly gay and bisexual men.
The $400 million national PrEP program would make HIV prevention available to un- and under-insured Americans.
LGBTQ and HIV news
Some people say they find long-acting injections more convenient than daily pills, which could increase uptake and adherence.
HIV advocates cheer: “In many ways, this is a very bold budget.” But they also call for a strategic national PrEP program.
In a letter to federal officials, PrEP4All and HIV advocates demand an update on the drug patent lawsuit “United States v. Gilead.”
Pharma giant Gilead Sciences again plays the villain in this story but there’s plenty of blame to go around.
Plus, nearly a third of people already taking Truvada for PrEP switched to the new combination pill.
The U.S. government and HIV drugmaker Gilead Sciences continue to fight over patents for Truvada and Descovy as PrEP.
Please help Peter Staley reach his birthday goal!
The POZ editors compiled the winners of the Fourth Annual POZ Awards.
Who owns the rights to PrEP? The U.S. government or the pharma giant?
Activists want the tech giant to take down similar ads with inaccurate claims about PrEP and HIV prevention.
More than 50 AIDS and LGBT groups demand the tech giant remove “dangerous and misleading” PrEP ads.
The U.S. Health Department launched “Ready, Set, PrEP” to provide the HIV prevention med at no cost.
The complaint alleges the company has profited from research spearheaded by the CDC.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.